Novel treatment options in the severe beta-globin disorders. - Wikidata - wikimedia - TriplyDB

Novel treatment options in the severe beta-globin disorders.

Novel treatment options in the severe beta-globin disorders.

http://www.wikidata.org/entity/Q40938157

about

CTD small phosphatase like 2 (CTDSPL2) can increase ε- and γ-globin gene expression in K562 cells and CD34+ cells derived from umbilical cord blood.Quantitative analysis of globin gene induction in single human erythroleukemic cells.Eos negatively regulates human γ-globin gene transcription during erythroid differentiation.Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.Genotypic correlation between six common beta-thalassemia mutations and the XmnI polymorphism in the Moroccan population.Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine.Hydroxyurea therapy for sickle cell disease in Britain. Disappointing recruitment despite promising results.Involvement of phosphatases in proliferation, maturation, and hemoglobinization of developing erythroid cells Flow cytometric analysis of hydroxyurea effects on fetal hemoglobin production in cultures of beta-thalassemia erythroid precursors.Induction of gamma-globin gene transcription by hydroxycarbamide in primary erythroid cell cultures from Lepore patients.Screening for trans-acting factors and other factors involved in the activating or silencing of the gamma-globin gene during human ontogeny.Heterogeneity of F cells in β-thalassemia.

P2860

Q33713346-56C11F45-3678-484B-919A-302A8B8022E0 Q33857209-DB75C4B9-92D1-4C69-B2FB-153355D75BF8 Q33988076-0FB7C30F-AF61-4F1E-9B5D-9DDECA2C909A Q37309900-1425B82B-9C8E-4B06-83C5-09BD6B91D2D3 Q38862466-1D2A6611-55C5-4379-9F77-5B91CB14641D Q40794098-84E7893C-2CC8-4FC6-BB47-DA3B31564816 Q42757173-C8EB8EFA-C469-4453-8248-93806A323E10 Q42826136-99B758E6-83B4-485E-81FE-E23794A5B263 Q44461260-00C4259F-4821-434A-B3E7-D1AFBF6EDD91 Q46636409-3A2E3DC1-94D3-4A62-AC09-D1A7645FC96A Q47574089-42140587-1437-470B-B571-3DA37EE39B88 Q50507887-8BBEF039-374B-4E9B-9DCC-5880A4A633B7

P2860

Novel treatment options in the severe beta-globin disorders.

http://www.wikidata.org/entity/Q40938157

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Novel treatment options in the severe beta-globin disorders.

@en

type

label

Novel treatment options in the severe beta-globin disorders.

@en

prefLabel

Novel treatment options in the severe beta-globin disorders.

@en

P1433

Q40938157-EC8856D7-604B-447A-9A9D-35F5890A29F9

P1476

Q40938157-BAADB58C-D7C7-4B78-8947-88621523542D

P2093

Q40938157-B12942EE-5704-42F8-AD26-DEE74C014933

Q40938157-E0B366F2-4D21-4214-9C4E-FE4688FB33F7

P2860

Q40938157-0807D0EB-6135-423F-AD13-1C7429DC5007

Q40938157-11CC18BC-C8C7-47A1-98CE-4FCBF2C5637F

Q40938157-2C291EB4-7736-47C6-BBBB-2E6333AA594A

Q40938157-3615E6CB-B3DE-45E6-9222-1C34F5173484

Q40938157-7A6C3FBE-953C-4917-AD8B-9EBDC7944BB2

Q40938157-7BFCF37F-D87E-40A8-AA44-AFF3E659BE09

Q40938157-A78A3A78-7F70-455C-BA59-E476E9C6C907

Q40938157-A9357A3D-B7E0-4F47-8567-760E937986A9

Q40938157-B14D0020-8E82-4EC7-AC4F-342A485876B7

Q40938157-B5FABFBF-739C-48B8-AB96-F581B7135274

P304

Q40938157-ED04BA60-DBA7-4A57-9441-DFC44AD2A96B

P31

Q40938157-9DB9334F-B09E-4DD9-A687-FEB8F12563EC

P356

Q40938157-2FBC0A27-763A-4182-95A9-58E60BA501C1

P407

Q40938157-F1861400-66AD-4FDE-A925-EC03DE37C52A

P433

Q40938157-AD2327C3-2B41-4695-95FD-8796F1E29F83

P478

Q40938157-BC634C27-D344-42CE-A0AB-C9D525745E9F

P577

Q40938157-FBBE852F-4C01-46AC-87DD-CE0D5CC0EB7F

P698

Q40938157-2F9E4A52-D584-4806-AE37-C69F0D880A8A

P356

J.1365-2141.1995.TB05288.X

P1433

British Journal of Haematology

P1476

Novel treatment options in the severe beta-globin disorders.

@en

P2093

Rachmilewitz EA

http://www.w3.org/2001/XMLSchema#string

Rodgers GP

http://www.w3.org/2001/XMLSchema#string

P2860

Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden.

Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma

Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.

Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

Fetal hemoglobin reactivation in baboon and man: a short perspective.

n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells.

5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells

Haemoglobinopathies and red cell membrane function.

P304

263-268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.1995.TB05288.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

1995-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8547060

http://www.w3.org/2001/XMLSchema#string